Frenkel Ran 4
4 · Karyopharm Therapeutics Inc. · Filed Feb 22, 2022
Insider Transaction Report
Form 4
Frenkel Ran
EVP, WW Development Operations
Transactions
- Sale
Common Stock
2022-02-17$12.12/sh−2,929$35,509→ 101,703 total
Footnotes (2)
- [F1]This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 17, 2022 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees.